Press release
Austrianova announces German subsidiary and new location in Singapore
Austrianova locations and key customers/partners globally
The German subsidiary, Austrianova Germany, at "Am Klopferspitz" in Martinsried, the world renowned German biotech centre, will function as Austrianova's European base, expanding the company's activities and reach.
This year has been a year of expansion for Austrianova. In August the company also moved to a new location in Singapore at "The Strategy" located in the International Business Park at Jurong, Singapore's new business district. This facility functions as the company's headquarters as well as being its Bac-in-a-Box® research facility and was made possible by an additional investment into the company by the US and Korea-based life sciences investment firm Checkmate Capital which has a special focus on cross-border transactions in Asia.
The Bac-in-a-Box® living cell encapsulation technology protects bacteria and yeast, allowing long-term storage at room temperature as well as protecting from the harmful, sterilizing effects of stomach acid and enzymes. Bac-in-a-Box® encapsulation has uses in diverse applications such as in probiotics or in the modification of the microbiome by selective and efficient delivery of bacteria to treat dysbiosis of the gastric tract, skin health etc. Austrianova Singapore is also gearing up to expand its Singapore facility for pilot scale production of Bac-in-a-Box® based bacterial and yeast products.
Earlier this year, the company also announced a capacity increase at its facility at Thailand Science Park, in the greater Bangkok metro area. At this location, the company has its state-of-the-art GMP and ISO9001:2015 qualified production and R&D labs. This facility focuses on the Cell-in-a-Box® cell encapsulation technology platform for protection of human and animal cells from immune rejection and clearance when implanted in the body, as well as for long-term storage in the frozen state. Besides working together with partners and clients who use the Cell-in-a-Box® technology, the facility also produces cell banks and other cell therapy related products.
Austrianova CEO, Brian Salmons, said "We are happy to report these new developments at Austrianova. Having a German subsidiary company supports and extends our current ongoing European activities in Austria, Italy, France, Spain and the U.K. as well as in Germany."
Walter H. Gunzburg, Chairman of Austrianova, added "The completion of Austrianova's move to our new custom designed facility in the heart of Singapore's Jurong region is key to the company's future success as is the expansion of the company into Europe with the new German daughter company."
www.austrianova.com
Brian Salmons
CEO, Austrianova
Austrianova Singapore: 2 International Business Park, The Strategy #09-04, Singapore 609930
Austrianova (the SG Austria Group), is a biotech company with a global footprint and operations in Singapore, Thailand and Germany. Austrianova utilizes a novel and proprietary technology for the encapsulation of living mammalian (Cell-in-a-Box®) and bacterial (Bac-in-a-Box®) cells. Cell-in-a-Box® protects the encapsulated cells from rejection by the immune system, allows cells to be easily transported, stored and implanted at specific sites in patients. The technology, which has been proven safe and efficacious in clinical trials carried out in Europe, allows companies to develop any kind of cells as a one-for-all living pharmaceutical. Bac-in-a-Box® is a similar protective device adapted for encapsulation of probiotic bacteria where it has human food and animal feed applications as well as rebalancing the microbiome due to its ability to extend storage under lyophilized conditions and to protect encapsulated bacteria against destruction by stomach acid. Austrianova now also offers GMP4Cells that includes competitively priced Master Cell Bank and Working Cell Bank production as well as "Fill and Finish" services for cell therapy products (such as stem cell therapies, biologics produced from cells e.g., vaccines, antibodies, enzymes, recombinant proteins, exosomes, etc.).
www.austrianova.com
Forward-Looking Statements
This release includes forward-looking statements regarding Austrianova / SGAustria (the Company) and its respective businesses. Such statements are based on the current expectations of the management of each entity. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including risks from economic factors and the equity markets generally. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Austrianova undertakes no obligation to publicly up-date or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. This is not an offer or solicitation to buy or sell any securities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Austrianova announces German subsidiary and new location in Singapore here
News-ID: 3271622 • Views: …
More Releases from Austrianova
Austrianova reports successful metronomic treatment using Cell-in-a-Box® in an …
SINGAPORE, December 19, 2023 - Austrianova, a member of the SGAustria group of companies, and a leading provider of cell encapsulated products as well as other biological products and services, today announced a newly published study demonstrating that one administration of Cell-in-a-Box® encapsulated cells followed by multiple rounds (metronomic) of low dose ifosfamide controls tumor growth in a mouse model of pancreatic cancer.*
Chemotherapeutics such as ifosfamide and cyclophosphamide are normally…
Austrianova and ProAgni sign a licensing and manufacturing agreement for novel, …
Austrianova and ProAgni announced today the signing of a licensing and manufacturing agreement that foresees an intensification of joint activities between the two companies in the area of development and commercialization of shelf stable probiotic additives for cattle feed as well as for other farm animals.
Austrianova, a Singaporean biotech company, has developed its patented Bac-in-a-Box® technology specifically to efficiently protect bacteria from stomach acid as well as to allow…
Austrianova and San Raffaele University & Research Hospital announce the initiat …
The group of Dr. Matteo Bellone, group leader Cellular immunology Unit at San Raffaele University & Research Hospital, has shown that Prevotella melaninogenica, a commensal bacterium of the human gastrointestinal microbiota, can protect against the progression of relatively benign asymptomatic multiple myeloma to the aggressive form of the disease. Delivery of Prevotella melaninogenica in preclinical animal models prevents this progression but large doses of the bacteria are needed since they…
Austrianova secures Investment from Checkmate Capital
SINGAPORE, March 02, 2023 (GLOBE NEWSWIRE) -- SG Austria ("Austrianova"), a leading provider of cell biological products and services, today announced that Checkmate Capital Group ("Checkmate Capital"), a multi-family investment and advisory group based in Pasadena, California, has made a preferred equity investment in SG Austria, the parent company of Austrianova.
SG Austria, with its Austrianova Singapore and Austrianova Thailand subsidiaries, has developed the Cell-in-a-Box® and Bac-in-a-Box® platforms, which use protective…
More Releases for Austria
Austria Agriculture Market | Austria Agriculture Industry | Austria Agriculture …
The share of Austria agriculture within the Austrian economy declined steady afterward World War II, agriculture continues to represent a very important part of the economy attributable to its social and political significance. The Chamber of Agriculture rests on an equal level with the chambers of commerce and labour, though its members manufactures solely a fraction of the GDP that industrial and sale able labours produce. Though little, the agricultural sector is…
Telecoms, Mobile and Broadband 2018-2023 Austria Market Survey Industry Key Play …
WiseGuyReports.com "Austria - Telecoms, Mobile and Broadband - Statistics and Analyses" report has been added to its Research Database.
Scope of the Report:
Austria's telcos looking forward to major spectrum auctions for 5G. Austria's telecom market is dominated by the incumbent Telekom Austria and the cableco UPC Austria, though there has been greater competitive pressure in the fixed-line broadband and mobile sectors in recent years. In common with operators elsewhere in Europe,…
Austria Telecoms, Mobile and Broadband Market Professional Survey with Industry …
WiseGuyReports.com “Austria - Telecoms, Mobile and Broadband - Statistics and Analyses” report has been added to its Research Database.
Scope of the Report:
Austria’s telcos looking forward to major spectrum auctions for 5G. Austria’s telecom market is dominated by the incumbent Telekom Austria and the cableco UPC Austria, though there has been greater competitive pressure in the fixed-line broadband and mobile sectors in recent years. In common with operators elsewhere in Europe,…
Agrochemicals Market in Austria
ReportsWorldwide has announced the addition of a new report title Austria: Agrochemicals: Market Intelligence (2016-2021) to its growing collection of premium market research reports.
The report “Austria: Agrochemicals: Market Intelligence (2016-2021)” provides market intelligence on the different market segments, based on type, active ingredient, formulation, crop, and pest. Market size and forecast (2016-2021) has been provided in terms of both, value (000 USD) and volume (000 KG) in the report. A…
Nazi psychology in Austria
The history of academic psychology after the "Anschluss", the annexation of Austria by Germany in 1938, and its role as a discipline used in National Socialist policies is being examined systematically for the first time in a research project supported by the Austrian Science Fund FWF.
"It is a sad fact”, says psychologist Gerhard Benetka from the Sigmund Freud University Vienna "that applied psychology flourished during the National Socialist era…
Creative Austria meets creative Russia
Euroforum: communicatin ready for the next lap
Vienna. On 22nd of October 2009 the advertising association Vienna invites again to the annual Euroforum: communication event, platform for European communication, guaranteeing an interesting mix of “connecting businesses and communications”. The Event takes place in Studio 44, Vienna.
Focus point Russia (Moscow, St. Petersburg and Sotschi)
The main goal of the Euroforum is to promote and establish business relations and synergies between…
